In conclusion, selected single nucleotide variants in GRIN2A and GRIN2B genes of NMDA-R are not associated with the selected clinical phenotype of patients in whom cognitive dysfunctions are present despite effective antipsychotic treatment of other schizophrenia symptoms. This evidence concerns the gene GRIN2B and schizophrenia.